These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9322235)

  • 1. Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene.
    Billett EA; Richter MA; King N; Heils A; Lesch KP; Kennedy JL
    Mol Psychiatry; 1997 Sep; 2(5):403-6. PubMed ID: 9322235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder.
    Bengel D; Greenberg BD; Corá-Locatelli G; Altemus M; Heils A; Li Q; Murphy DL
    Mol Psychiatry; 1999 Sep; 4(5):463-6. PubMed ID: 10523819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study of the serotonin transporter gene polymorphism in obsessive-compulsive disorder.
    Camarena B; Rinetti G; Cruz C; Hernández S; de la Fuente JR; Nicolini H
    Int J Neuropsychopharmacol; 2001 Sep; 4(3):269-72. PubMed ID: 11602033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder.
    Meira-Lima I; Shavitt RG; Miguita K; Ikenaga E; Miguel EC; Vallada H
    Genes Brain Behav; 2004 Apr; 3(2):75-9. PubMed ID: 15005715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder.
    McDougle CJ; Epperson CN; Price LH; Gelernter J
    Mol Psychiatry; 1998 May; 3(3):270-3. PubMed ID: 9672904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between serotonergic candidate genes and specific phenotypes of obsessive compulsive disorder.
    Denys D; Van Nieuwerburgh F; Deforce D; Westenberg HG
    J Affect Disord; 2006 Mar; 91(1):39-44. PubMed ID: 16443280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder.
    Delorme R; Chabane N; Callebert J; Falissard B; Mouren-Siméoni MC; Rouillon F; Launay JM; Leboyer M
    J Clin Psychopharmacol; 2004 Feb; 24(1):18-23. PubMed ID: 14709942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism.
    Cavallini MC; Di Bella D; Siliprandi F; Malchiodi F; Bellodi L
    Am J Med Genet; 2002 Apr; 114(3):347-53. PubMed ID: 11920862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response.
    Di Bella D; Erzegovesi S; Cavallini MC; Bellodi L
    Pharmacogenomics J; 2002; 2(3):176-81. PubMed ID: 12082589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial.
    Denys D; Van Nieuwerburgh F; Deforce D; Westenberg HG
    J Clin Psychiatry; 2007 May; 68(5):747-53. PubMed ID: 17503984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of evidence for association between serotonin transporter gene (5-HTTLPR) and obsessive-compulsive disorder by case control and family association study in humans.
    Chabane N; Millet B; Delorme R; Lichtermann D; Mathieu F; Laplanche JL; Roy I; Mouren MC; Hankard R; Maier W; Launay JM; Leboyer M
    Neurosci Lett; 2004 Jun; 363(2):154-6. PubMed ID: 15172105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intact coding region of the serotonin transporter gene in obsessive-compulsive disorder.
    Altemus M; Murphy DL; Greenberg B; Lesch KP
    Am J Med Genet; 1996 Jul; 67(4):409-11. PubMed ID: 8837711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways.
    Frisch A; Michaelovsky E; Rockah R; Amir I; Hermesh H; Laor N; Fuchs C; Zohar J; Lerer B; Buniak SF; Landa S; Poyurovsky M; Shapira B; Weizman R
    Eur Neuropsychopharmacol; 2000 May; 10(3):205-9. PubMed ID: 10793323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine.
    Whale R; Quested DJ; Laver D; Harrison PJ; Cowen PJ
    Psychopharmacology (Berl); 2000 May; 150(1):120-2. PubMed ID: 10867985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder.
    Hanna GL; Himle JA; Curtis GC; Koram DQ; Veenstra-VanderWeele J; Leventhal BL; Cook EH
    Neuropsychopharmacology; 1998 Feb; 18(2):102-11. PubMed ID: 9430134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot genetic study of the continuum between compulsivity and impulsivity in females: the serotonin transporter promoter polymorphism.
    Baca-García E; Salgado BR; Segal HD; Lorenzo CV; Acosta MN; Romero MA; Hernández MD; Saiz-Ruiz J; Fernandez Piqueras J; de Leon J
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):713-7. PubMed ID: 15908092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse.
    Weizman A; Weizman R
    Pharmacogenomics; 2000 Aug; 1(3):335-41. PubMed ID: 11256582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of the serotonin transporter: implications for the use of selective serotonin reuptake inhibitors.
    Lotrich FE; Pollock BG; Ferrell RE
    Am J Pharmacogenomics; 2001; 1(3):153-64. PubMed ID: 12083964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of SLC1A1 gene polymorphism with obsessive compulsive disorder in a sample from southern India.
    Shukla T; Nadella RK; Taj M J RJ; Ganesh S; Nestadt G; Purushottam M; Jain S; Reddy YCJ; Viswanath B
    Exp Clin Psychopharmacol; 2020 Dec; 28(6):617-621. PubMed ID: 31985241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between obsessive-compulsive disorder and a variable number of tandem repeats polymorphism in intron 2 of the serotonin transporter gene.
    Baca-Garcia E; Vaquero-Lorenzo C; Diaz-Hernandez M; Rodriguez-Salgado B; Dolengevich-Segal H; Arrojo-Romero M; Botillo-Martin C; Ceverino A; Piqueras JF; Perez-Rodriguez MM; Saiz-Ruiz J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):416-20. PubMed ID: 17174018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.